- Amicus Therapeutics (FOLD, Financial) is set to announce its Q1 2025 financial results on May 1, 2025.
- The live conference call and webcast will start at 8:30 a.m. ET, covering performance up to March 31, 2025.
- Participants must pre-register online for phone access, with materials available on ir.amicusrx.com.
Amicus Therapeutics (FOLD) has officially scheduled a conference call and audio webcast to release its financial results for the first quarter of 2025. The event will be held on Thursday, May 1, 2025, at 8:30 a.m. ET. This discussion will cover financial performance for the quarter ending on March 31, 2025.
Investors and participants interested in the call must complete an online registration to receive the necessary dial-in details and a personalized PIN for telephonic access. Furthermore, a live webcast and associated presentation materials will be available through the Investors section of the Amicus website at ir.amicusrx.com. Interested parties are advised to register at least 15 minutes before the call commences.
For those unable to attend the live event, an archived version of the webcast and presentation slides will be accessible on the company's website following the conclusion of the call.
Amicus Therapeutics (FOLD, Financial) is a global biotechnology company dedicated to developing innovative medicines for individuals with rare diseases, continually striving to advance a portfolio of cutting-edge therapies. More information can be found on their official site, www.amicusrx.com.
